Leading figures in the HIV response have endorsed a call for
immediate access to antiretroviral therapy for all people upon diagnosis with
HIV, on the opening day of the 8th International AIDS Society Conference on
HIV Pathogenesis, Treatment in Prevention (IAS 2015) in Vancouver on Sunday.
The Vancouver Consensus Statement has been endorsed by
leaders of major agencies including the Global Fund to Fight AIDS, Tuberculosis
and Malaria, the US President's Emergency Plan for AIDS Relief (PEPFAR) and UNAIDS, and
is intended to place pressure on donors and governments to support expanded
treatment and prevention.
“Let this be the conference where the question of when to start treatment stops being a scientific question and starts being a question of finance and political will.” Professor Chris Beyrer
The statement calls for immediate access to antiretrovirals
and for access to pre-exposure prophylaxis for those at high risk of HIV
exposure, and urges rapid progress towards the implementation of new scientific
evidence.
“Let this be the conference where the question of when to
start treatment stops being a scientific question and starts being a question
of finance and political will,” Professor Chris Beyrer of Johns Hopkins University
told the opening plenary of the conference. “This conference will be a line in
the sand in the HIV response.”
“There is no discussion any more, the science is in […] IAS
2015 will finally complete a body of irrefutable evidence to make treatment as
prevention the global standard of care,” Professor Julio Montaner of the
University of British Columbia Centre of Excellence in HIV said, welcoming delegates
to Vancouver.
Vancouver played host to a major turning point of the HIV
epidemic in 1996, when the International AIDS Conference in the city heard
results of major studies showing that three-drug antiretroviral therapy, or
highly active antiretroviral therapy (HAART), provided the first truly effective
treatment for HIV.
Professor Montaner reminded delegates how much has
been achieved since 1996, not least extending access to treatment to 15 million
people worldwide in 2015.
“Political leaders of the world, you are with us or against
us,” Prof. Montaner said.
Michel Sidibe, Executive Director of UNAIDS, expressed
concern regarding donor commitment to funding an expanded HIV response. UNAIDS
estimates that a further $8 to $12 billion is needed each year until 2030 to
drive down new infections through expansion of antiretroviral treatment and
combination HIV prevention. Sidibe warned “If we don’t have the resources I
think we will have difficulty in sustaining our gains.”